METABOLISM ENHANCING COMPOSITIONS

MICROTUBULE POLYMERIZATION INHIBITOR PRODRUGS AND METHODS OF USING THE SAME

PSYCHOACTIVE MEDICINES AND THEIR USE FOR TREATING PSYCHIATRIC AND NEUROLOGICAL CONDITIONS AND DISORDERS

TRANSDERMAL DELIVERY FORMULATIONS AND METHODS FOR THE MANUFACTURE THEREOF

Methods and Dosing Regimens for Preventing or Delaying Onset of Alzheimer's Disease and Other Forms of Dementia and Mild Cognitive Impairment

INFLAMMATORY DISORDER IN A FELIDAE

METHODS OF IDENTIFYING AND TREATING TUMORS WITH SIGMA1 INHIBITORS

THERAPEUTIC AGENT FOR TREATING HIF-1alpha-MEDIATED DISEASES BY INHIBITING AREL1 AND RESTORING PHD2 ACTIVITY

M1 VIRUS MUTANT AND USE THEREOF

Methods for Determining the Likelihood of Survival and for Predicting Likelihood of Metastasis in Cancer Patients

ANTI-LEWIS Y ANTIBODY AND PRO-ANTIBODY THEREOF

COMPOSITIONS OF IL-6/IL-6R ANTIBODIES AND METHODS OF USE THEREOF

Bispecific EGFR/C-Met Antibodies

NOVEL ANTI-LILRB4 ANTIBODIES AND DERIVATIVE PRODUCTS

Antibodies Binding to ILT4

METHODS OF USING ACTIVIN RECEPTOR TYPE II VARIANTS

RELAXIN ANALOGS AND METHODS OF USING THE SAME

VEGETATION MANAGEMENT SYSTEM AND VEGETATION MANAGEMENT METHOD

SYNTHETIC TRIPLEX PEPTIDE NUCLEIC ACID-BASED INHIBITORS FOR CANCER THERAPY

Androstane Derivatives with Activity as Pure or Predominantly Pure Stimulators of SERCA2a for the Treatment of Heart Failure

BORON-CONTAINING RHO KINASE INHIBITORS

PROCESS FOR THE PREPARATION OF TRICYCLIC PI3K INHIBITOR COMPOUNDS AND METHODS FOR USING THE SAME FOR THE TREATMENT OF CANCER

SALTS, CRYSTAL FORMS, AND PRODUCTION METHODS THEREOF

PYRIMIDINE INDOLES AS CDK4 INHIBITORS

SUBSTITUTED 1H-PYRAZOLO-PYRIDINE AND -PYRIMIDINE COMPOUNDS

PI3K-ALPHA INHIBITORS AND METHODS OF MAKING AND USING THE SAME

CANCER TREATMENTS TARGETING CANCER STEM CELLS

l,2-SUBSTITUTED 3-OXOPYRAZOLIDINE DERIVATIVES AS PROSTAGLANDIN E2 RECEPTOR 4 (EP4) AGONISTS FOR THE TREATMENT OF GASTROINTESTINAL AND PULMONARY DISEASES

SALTS AND SOLID FORMS OF N-ETHYL-2-(5-FLUORO-1H-INDOL-3-YL)-N-METHYLETHAN-1-AMINE

BITE-ACTIVATED CAR-T CELLS

COMPOSITIONS COMPRISING SULFORAPHANE OR A SULFORAPHANE PRECURSOR AND A MILK THISTLE EXTRACT OR POWDER

DECORIN FOR ITS USE IN THE TREATMENT OF DIABETES

ISOCYCLOSPORIN A FOR TOPICAL TREATMENT OF OCULAR DISEASES

QUORUM-SENSING INHIBITORS AND/OR POSTBIOTIC METABOLITES AND RELATED METHODS

STRAIN OF SACCHAROMYCES CEREVISIAE VAR. BOULARDII FOR TREATING INFECTIOUS DISEASES OF THE ORAL CAVITY

AMMONIA OXIDIZING MICROORGANISMS FOR THE TREATMENT OF PULMONARY HYPERTENSION

METHODS FOR TREATING EARLY ALZHEIMER’S DISEASE

METHOD FOR INCREASING POLLINATION IN CROPS SUSCEPTIBLE TO POLLINATION OF INVERTEBRATES OF THE APIDEAE FAMILIES

STAPHYLOCOCCUS AUREUS PBP4 INHIBITORS AND METHOD OF USE

COMPOSITION CONTAINING LAMOTRIGINE, AND PREPARATION METHOD AND USE THEREOF

THERAPEUTIC CONSTRUCTS FOR CO-DELIVERY OF ANTI-CANCER AGENT(S) AND IMMUNE CHECKPOINT INHIBITOR(S)

METHOD FOR TREATING A DISEASE OR CONDITION USING A PYRAZOLE COMPOUND OR FORMULATION THEREOF

METHODS AND DEVICES FOR THE TREATMENT OF OCULAR DISEASES IN HUMAN SUBJECTS

METHOD OF TREATING AFFECTIVE DISORDERS AND PERSONALITY DISORDERS

CO-THERAPIES INCLUDING A METASTASIS INHIBITOR

ENHANCEMENT OF FIBROBLAST PLASTICITY FOR TREATMENT OF DISC DEGENERATION

RECOMBINANT MONOCLONAL ANTIBODIES AND CORRESPONDING ANTIGENS FOR COLON AND PANCREATIC CANCERS

VHH ANTIBODIES AND USES THEREOF

ANTIBODY MOLECULES TO APRIL AND USES THEREOF

ANTI-B7H3 ANTIBODIES AND METHODS OF USE

COMBINATION OF A PD-1 ANTAGONIST AND A VEGFR INHIBITOR FOR TREATING CANCER

NOVEL SIRP NANOBODIES

MONOCLONAL ANTIBODIES TO GROWTH AND DIFFERENTIATION FACTOR 15 (GDF-15)

NOVEL CD200 FUSION PROTEINS

HETEROAROMATIC INDOLESULFONAMIDES

ISOXAZOLE HYDROXAMIC ACIDS AS HISTONE DEACETYLASE 6 INHIBITORS

INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOFS

ORALLY ACTIVE MELANOCORTIN RECEPTOR-4 COMPOUNDS

2-(2,5-DIETHOXY-4-(ETHYLTHIO)PHENYL)ETHANE-1-AMINIUM CHLORIDE

MOLECULES AND THEIR DERIVATIVES DIRECTED AGANIST CD45

CONJUGATES, COMPOSITIONS, AND METHODS FOR HYDROXYAPATITE-TARGETED IMAGING AND THERAPY

CONJUGATES, COMPOSITIONS, AND METHODS FOR HYDROXYAPATITE-TARGETED IMAGING AND THERAPY

CDH17-BINDING ANTIBODIES AND METHODS OF USE THEREOF

TOXICITY MANAGEMENT FOR ANTI-TUMOR ACTIVITY OF CARS

TRITERPENE SAPONIN ANALOGUES

Hyaluronidase Enzyme Formulations for High Volume Administration

HUMAN AMYLIN ANALOG, AND DERIVATIVE THEREOF AND USE THEREOF

METHODS AND COMPOSITIONS FOR TREATMENT OF ENDOTHELIN B RECEPTOR EXPRESSING TUMORS

COMPOSITION FOR INDUCING PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS

EXTRACELLULAR VESICLES FOR THERAPY

TREATMENT AND/OR PREVENTION OF SKELETAL MUSCLE ATROPHY BY INHIBITION OF EDA2R-NIK AND OSM-OSMR SIGNALING PATHWAYS

TREATMENT OF ADVANCED METASTATIC CANCER

ENTHESIS HEALING

POTENTIAL THERAPEUTICS FOR FIBROSIS BY BLOCKING THE INCREASE OF A KEY ENZYME

DIRECT DELIVERY OF ANTIOXIDANTS TO THE GUT

Combination Treatment Regimens - SMARCA2 Degrader With Taxane Anticancer Agent

METHODS OF TREATING CENTERAL NERVOUS SYSTEM DISORDERS COMPRISING ADMINISTERING DEUTERATED LUMATEPERONE AND A NITRIC OXIDE DONOR

USE OF RECA INHIBITOR AND DERIVATIVE COMPOUNDS FOR CANCER TREATMENT

ALLOSTERIC MODULATORS OF CANNABINOID RECEPTORS AND METHODS OF TREATING NEUROPATHIC PAIN

COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF PHOTORECEPTOR ROD DEGENERATIONS AND GENERATION OF PHOTORECEPTORS

INHIBITORS OF GLUCOSYLCERAMIDE SYNTHASE

2-HYDROXY-OCTADECENE-9-CIS-OATE FOR USE IN THE TREATMENT OF ONCOLOGICAL PATHOLOGIES AND NEUROPATHIC PAIN

Methods for Providing Rapid Relief of Motor Fluctuations in a Parkinson's Disease Patient

STABLE FORMS OF CAPSAICIN PALMITATE FOR THE TREATMENT OF PAIN

METHODS FOR SELECTION OF CANCER PATIENTS FOR ANTI-ANGIOGENIC AND IMMUNE CHECKPOINT BLOCKAGE THERAPIES AND COMBINATIONS THEREOF

COMPOSITIONS AND METHODS TO MODULATE TUMOR MICROENVIRONMENT ASSOCIATED LONG NONCODING RNAS

THERAPEUTIC OLIGONUCLEOTIDES TO CORRECT CYSTIC FIBROSIS MUTATIONS

ANTI-HER2 ANTIBODIES AND METHODS OF USE THEREOF

COMPOSITIONS AND METHODS FOR TREATING CANCER

Colon and Pancreas Cancer Peptidomimetics

4-(IMIDAZO[1,2-A]PYRIDIN-3-YL)-PYRIMIDINE DERIVATIVES

PEROXIREDOXIN 3 INHIBITORS AND METHODS OF USE FOR TREATING CANCER

C7-FLUORO SUBSTITUTED TETRACYCLINE COMPOUNDS

NEURO-ATTENUATING KETAMINE AND NORKETAMINE COMPOUNDS, DERIVATIVES THEREOF, AND METHODS

Peptide Composition for Cancer Approach and Diagnosis

Drug-Resistant Immune Cells and Methods of Use Thereof

COMPOSITIONS FOR IMPROVED NRF2 ACTIVATION AND METHODS OF THEIR USE

METHODS AND COMPOSITIONS FOR REDUCING CLOSTRIDIUM DIFFICILE INFECTION

MAGNESIUM SALTS COMPOSITION

LIPOSOMAL FORMULATIONS OF BCL INHIBITORS

FUSED AMINO PYRIMIDINE COMPOUNDS FOR TREATMENT OF TINNITUS, ACUTE SENSORINEURAL HEARING LOSS, AGE-RELATED HEARING LOSS, AND MENIERE'S DISEASE

METHODS OF TREATING A RAS PROTEIN-RELATED DISEASE OR DISORDER

METHOD OF INHIBITING EPITHELIAL-MESENCHYMAL TRANSITION AND CANCER METASTASIS

Combination of Talazoparib and Enzalutamide in the Treatment of Metastatic Castration-Resistant Prostate Cancer

THERAPEUTIC AGENT FOR NON-MOTOR SYMPTOMS ASSOCIATED WITH PARKINSON'S DISEASE

TREATMENT OF AUTOIMMUNE DISEASE IN A PATIENT RECEIVING ADDITIONALLY A BETA-BLOCKER

MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X4 AND RELATED PRODUCTS AND METHODS

OIL IN WATER MICROEMULSION FORMULATION

POLYNUCLEOTIDE AGENTS TARGETING PROGRAMMED CELL DEATH 1 LIGAND 1 (PD-L1) AND METHODS OF USE THEREOF

C-MYC-TARGETING CHARGE-ALTERING RELEASABLE TRANSPORTERS AS ANTI-TUMOR AGENTS FOR BREAST CANCER THERAPY

COMPOSITION AND METHOD FOR INHIBITING ANGIOTENSINOGEN (AGT) PROTEIN EXPRESSION

COMPOSITIONS AND METHODS FOR ADOPTIVE CELL THERAPY FOR CANCER

HUMAN CD163 ANTIBODIES AND USES THEREOF

ANTI-OPG ANTIBODIES

PHARMACEUTICAL COMPOSITIONS OF HUMANIZED ANTI-CD40 ANTIBODIES AND USES THEREOF

TIE2-BINDING AGENTS AND METHODS OF USE

PLK1 INHIBITOR IN COMBINATION WITH ANTI-ANGIOGENICS FOR TREATING METASTATIC CANCER

DIFFERENT FORMS OF 6-CHLORO-2-ETHYL-N-(4-(4-(4(TRIFLUOROMETHOXY)PHENYL)PIPERIDINE-1-YL)BENZYL)IMIDAZO[1,2-A]PYRIDINE-3-CARBOXAMIDE

ESTROGEN RECEPTOR MODULATORS AND USES THEREOF

CFTR REGULATORS AND METHODS OF USE THEREOF

CHOLINERGIC GENE THERAPY TO PRESERVE HEARING

PKC INHIBITORS FOR THE TREATMENT OF SEPTIC CHOLESTASIS WITH POLYMETHINE DYE TARGETING

COMPOSITIONS WITH REDUCED NITROSAMINE IMPURITIES

Tumor-Associated Antigen Based Cancer Vaccine

DUAL ACTING POLYMERS IN AN OSMOTIC FILM FOR TOPICAL APPLICATION TO TREAT INFLAMMATORY DISEASES AND CYTOKINE RELEASE SYNDROME

ONCOLYTIC ADENOVIRAL VECTOR AND METHODS OF USE

COMPOSITION FOR CANCER IMMUNOTHERAPY COMPRISING SECONDARY LYMPHOID ORGAN-DERIVED EXTRACELLULAR VESICLE AS ACTIVE INGREDIENT

4'-HALOGEN CONTAINING NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO

COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF CANCER

COMPOSITIONS COMPRISING PRODRUGS OF HYDROXAMATE-BASED COMPOUNDS AND METHODS OF MAKING AND USING SAME

USE OF DERIVATIVES CONTAINING C-O-P BONDS IN PATIENTS WITH KIDNEY FAILURE

SUBSTITUTED QUINAZOLINES FOR INHIBITING KINASE ACTIVITY

ORAL FORMULATIONS OF THR-BETA AGONIST

PHARMACEUTICAL COMPOSITION FOR DISRUPTING TUMOR BLOOD VESSELS

PHARMACEUTICAL COMPOSITION FOR TREATING LEUKEMIA COMPRISING FLT3 INHIBITOR

NEW THERAPEUTIC APPROACH TO LUNG DISEASE

PYRAZOLO[3,4-B]PYRAZINE SHP2 PHOSPHATASE INHIBITORS

USE OF HEXOKINASE 2/MITOCHONDRIA-DETACHING COMPOUNDS FOR TREATING HEXOKINASE-2 (HK2)-EXPRESSING CANCERS

PHARMACEUTICAL COMBINATIONS FOR TREATING CANCER

LYMPH DIRECTING PRODRUGS

COMBINATION TREATMENT OF DERMAL AND TRANSDERMAL FIBROTIC DISEASES, DISORDERS AND ASSOCIATED PAIN AND INFLAMMATION

IMMUNE CELLS EXPRESSING ENGINEERED ANTIGEN RECEPTORS

Treating herpesvirus-mediated intestinal dysfunction for prevention of age-related neurodegeneration

ANTI-SOLUBLE INTERLEUKIN-7 RECEPTOR ANTIBODY THERAPY TO TREAT AUTOIMMUNE DISEASES

FUSIONS WITH CD8 ANTIGEN BINDING MOLECULES FOR TREATING CHRONIC VIRAL INFECTION

ANTAGONIST ANTI-CD7 ANTIBODIES

USE OF A SMALL NATIVE PEPTIDE ACTIVATOR OF SERCA PUMP FOR TREATMENT OF HEART FAILURE AND OTHER DISORDERS CHARACTERIZED BY CYTOSOLIC CALCIUM OVERLOAD

Method of Treatment Using a Pharmaceutical Composition Comprising a p80 Protein

2-HETEROARYL-3-OXO-2,3-DIHYDROPYRIDAZINE-4-CARBOXAMIDES FOR THE TREATMENT OF CANCER

Compounds and Their Use for Treatment of Hemoglobinopathies

SYNTHESIS OF NSAID CONJUGATES AS ANTI-INFLAMMATORY AGENTS USING THE MOLECULAR HYBRIDIZATION

MODIFIED ONCOLYTIC HERPES SIMPLEX VIRUS (oHSV) AND METHODS OF USE THEREOF

ONCOLYTIC VACCINIA VIRUSES AND RECOMBINANT VIRUSES AND METHODS OF USE THEREOF

ETHER LIPIDS FOR HYPERACTIVATION OF MAMMALIAN DENDRITIC CELLS

AMNIOTIC FLUID COMPOSITION AND METHOD OF USING

Methods of Treating Myeloproliferative Neoplasms

BIOFILM DISRUPTION

METHOD OF ANALYZING TUMOR SITE-SPECIFIC GENE MUTATION AND AN APPARATUS THEREFOR

Bcl2 Family in Dysfunctional Neurons Is Critical to the Evolution, Diagnosis and Treatment of Neurodegenerative Diseases Including but Not Limited to Corticobasal Degeneration, Chronic Traumatic Encephalopathy, Amyotrophic Lateral Sclerosis (Als), Alzheimer's Disease, Parkinson's Disease, Down's Syndrome Dementia, and Lewy Body Dementia

PRODUCTS AND COMPOSITIONS

SERIES OF POLYMERS HAVING PROPERTIES OF ACID-SENSITIVE DEGRADATION AND TEMPERATURE SENSITIVITY AND DRUG LOADING COMPOSITION THEREOF

PLK1 INHIBITOR IN COMBINATION WITH ANTI-ANGIOGENICS FOR TREATING METASTATIC CANCER

ANTI-C1S ANTIBODIES AND METHODS OF USE THEREOF

MULTIMERIC IL-15 SOLUBLE FUSION MOLECULES AND METHODS OF MAKING AND USING SAME

Method of Making a Pharmaceutical Composition Comprising a p80 Protein

KRAS INHIBITORS

FUSED BICYCLIC RAF INHIBITORS AND METHODS FOR USE THEREOF

Broad Spectrum Antiviral Compositions and Methods

KHK INHIBITORS

NANOCOMPOSITE FOR TARGETED DEGRADATION OF PATHOGENIC PROTEIN, PREPARATION METHOD THEREFOR, AND USE THEREOF

SAPOSIN-A DERIVED PEPTIDES AND USES THEREOF

USE OF NMN FOR THE PREVENTION AND/OR TREATMENT OF PAIN, AND CORRESPONDING COMPOSITIONS

COMPOSITIONS AND METHODS FOR ENHANCING WNT SIGNALING FOR TREATING CANCER

PRODRUGS OF RILUZOLE AND THEIR METHOD OF USE

TREATMENTS FOR INFLAMMATION

Methods Of Treating Meduloblastoma With Thyroid Hormone

METHODS OF TREATMENT OF TEMOZOLOMIDE-RESISTANT GLIOMA USING COENZYME Q10

DRUG DELIVERY SYSTEM

TRANSDERMAL DELIVERY FORMULATIONS

Using Multiple Heteroresistance to Guide Combination Antimicrobial Regimens

Carrier-PD-L1 Binding Agent Compositions for Treating Cancers

Methods and Treatment Involving Excess Free LIGHT

METHODS OF ANTIGEN PRODUCTION

METHOD FOR THE TREATMENT OF AN ACUTE RESPIRATORY DISTRESS SYNDROME

HETEROCYCLIC DERIVATIVES AS JANUS KINASE INHIBITORS

LEUCINE RICH REPEAT KINASE 2 (LRRK2) DEGRADING COMPOUNDS AND ASSOCIATED METHODS OF USE

ACSS2 INHIBITORS AND METHODS OF USE THEREOF

SALTS AND SOLID FORMS OF 4-HYDROXY-N,N-DIISOPROPYLTRYPTAMINE HEMI-GLUTARATE AND HEMI-SUCCINATE

POLYNUCLEOTIDES TARGETING NR4A3 AND USES THEREOF

COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING TUMOR TREATING FIELDS (TTFIELDS) AND INTERFERON GAMMA

CORTICOSTEROID CONTAINING ORALLY DISINTEGRATING TABLET COMPOSITIONS FOR EOSINOPHILIC ESOPHAGITIS

SMALL MOLECULE INHIBITORS OF KRAS PROTEINS

USE OF TAVAPADON IN TREATING PARKINSON'S DISEASE

ABHD6 ANTAGONIST

DOSAGE FORMS FOR TYK2 INHIBITORS

DOSAGE FORMS FOR TYK2 INHIBITORS

SIGMARI LIGAND FOR THE TREATMENT OF PANCREATIC CANCER

5HT AGONISTS FOR TREATING DISORDERS

PSYCHOACTIVE MEDICINES AND THEIR USE FOR TREATING PSYCHIATRIC AND NEUROLOGICAL CONDITIONS AND DISORDERS

METHODS OF TREATING DISEASE WITH DICHLORPHENAMIDE

COMPOUNDS FOR REDUCING LACTATION AND IMPROVING HEALTH

METHODS OF PERMEABILIZING THE BLOOD BRAIN BARRIER

ORALLY ADMINISTERED CORTICOSTEROID COMPOSITIONS

METHOD OF TREATING DISEASE

METHODS AND SYSTEMS FOR PREDICTING A DISEASE STATE BASED ON ANALYZING CFDNA FRAGMENTS

SYSTEMS AND METHODS FOR CLASSIFYING AND TREATING HOMOLOGOUS REPAIR DEFICIENCY CANCERS

METHODS OF DETECTING SJÖGREN'S SYNDROME USING SALIVARY EXOSOMES

ANTI-TL1A ANTIBODY THERAPEUTIC METHODS

Bispecific Tetravalent Antibodies and Methods of Making and Using Thereof

LAG-3 COMBINATION THERAPY FOR THE TREATMENT OF CANCER

AMATOXIN ANTIBODY-DRUG CONJUGATES AND USES THEREOF

COMPOSITIONS AND METHODS FOR TREHALOSE PHOSPHOLIPIDS

COMPOUNDS, COMPOSITIONS, AND METHODS FOR MODULATING CFTR

POLYCYCLIC QUINAZOLINES FOR INHIBITION OF ERBB2

RAS INHIBITORS

BICYCLIC UREA KINASE INHIBITORS AND USES THEREOF

INHIBITORS OF ENL/AF9 YEATS AND FLT3

DEGRADER COMPOUNDS AND USES THEREOF

COMBINATION THERAPY FOR THE TREATMENT OF DEPRESSION

PHARMACEUTICAL COMPOSITIONS COMPRISING MELOXICAM

CANCER THERAPY

METHODS OF TREATING PSORIATIC ARTHRITIS USING IL-17 ANTAGONISTS

METHODS FOR TREATING CANCER WITH HYPERACTIVE ADAR ENZYMES

SIALYLATED GLYCOPROTEIN COMPOSITION AND USES THEREOF

Core four dietary supplement system

CELLULAR IMMUNOTHERAPY COMPOSITIONS AND USES THEREOF

METABOLIC MODULATION OF INTRATUMORAL CHOLESTEROL WITH ENGINEERED BACTERIA FOR THE TREATMENT OF CANCERS

TREATMENT FOR HEART FAILURE WITH PRESERVED EJECTION FRACTION WITH GUANETHIDINE AND GUANADREL

ANTIDIABETIC MEDICATIONS

METHODS OF TREATING EPILEPSY AND REDUCING THE INCIDENCE OF SEIZURES

METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER

AZA-QUINOLINE COMPOUNDS AND USES THEREOF

HETEROCYCLIC DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND THEIR USE IN THE TREATMENT OR AMELIORATION OF CANCER

COMBINATION TREATMENTS

METHODS FOR REGRESSING OR REVERSING FIBROSIS AND/OR LIVER CIRRHOSIS IN A SUBJECT IN NEED THEREOF USING HIGH-DOSE NIACIN, OR A NIACIN ANALOG THEREOF

COMPOSITIONS AND METHODS FOR REDUCING CANCER STEM CELLS

METHODS OF DIAGNOSING AND TREATING ADHD IN BIOMARKER POSITIVE SUBJECTS

USE OF A PHOSPHODIESTERASE 10 INHIBITOR FOR THE TREATMENT OF TOURETTE SYNDROME

AGENTS THAT TARGET TELOMERASE REVERSE TRANSCRIPTASE (TERT) FOR TREATING CANCER AND SENSITIZING CANCER CELLS TO GENOTOXIC THERAPY

PREVENTION AND TREATMENT OF CONDITIONS USING ETHYL PYRUVATE

METHODS FOR PROMOTING NERVE GROWTH

TARGETED RELEASE RIFAXIMIN COMPOSITIONS

DRY POWDER FORMULATIONS OF EPINEPHRINE AND ASSOCIATED METHODS

CONTINUOUS OR PERIODICAL TRANSDERMAL DELIVERY OF EXOGENOUS MOLECULE

UNIVERSAL NATURAL KILLER CELLS DERIVED FROM HUMAN PLURIPOTENT STEM CELLS AND METHOD OF USE

BISPECIFIC HER2 AND CD3 BINDING MOLECULES

METHODS FOR TREATING BULLOUS PEMPHIGOID BY ADMINISTERING AN IL-4R ANTAGONIST

Treatment of Non-Small Cell Lung Cancer with EGFR Mutations

ACTRII ANTIBODY FIXED UNIT DOSE TREATMENTS

METHODS AND COMPOSITIONS INVOLVING CHIMERIC BINDING POLYPEPTIDES

ANTI-GDF15 ANTIBODY FOR NEOADJUVANT THERAPY OF CANCER

TYR PEPTIDE COMPOSITIONS AND METHODS FOR USE

N-SUBSTITUTED TETRAHYDROTHIENOPYRIDINE DERIVATIVES AND USES THEREOF

Derivatives of Imidazo[1,2-A]Pyridine with Anti-Inflammatory Activity

Inhibitors of Dihydroceramide Desaturase for Treating Disease

SYSTEMS, DEVICES AND METHODS FOR MODULAR FUNCTIONALIZED CELLULAR NANOSTRUCTURES FOR TARGETED PAYLOAD DELIVERY

METHOD OF TREATING CANCER

Combined therapy of photodynamic therapy and immune checkpoint inhibitor

MODIFIED T-CELLS FOR USE IN THE TREATMENT OF HEAD AND NECK CANCER

THERAPY INVOLVING ANTIBODIES AGAINST CLAUDIN 18.2 FOR TREATMENT OF CANCER

Combination treatment for atopic dermatitis

FIBROIN-DERIVED PROTEIN COMPOSITION

Nutritive Polypeptides and Formulations Thereof, and Methods of Production and Use Thereof

ENCAPSULATED CANNABINOID FORMULATIONS FOR TRANSDERMAL DELIVERY

AMMONIA OXIDIZING MICROORGANISMS FOR USE AND DELIVERY TO THE INTRANASAL SYSTEM

METHOD FOR THE TREATMENT OF AN AUDITORY DISEASE OR CONDITION

METHODS AND USE FOR BIOENGINEERING ENUCLEATED CELLS

ORGANIC COMPOSITIONS TO TREAT KRAS-RELATED DISEASES

COMBINATION TUMOR IMMUNOTHERAPY

CANNABINOID ACID ESTER COMPOSITIONS AND USES THEREOF

COMPOSITIONS COMPRISING CANNABINOIDS AND METHODS OF USE

INHIBITORS OF BROMODOMAIN-CONTAINING PROTEIN 4 AND PHOSPHOINOSITIDE 3-KINASE

USE OF PLK1 INHIBITOR AS MONOTHERAPY AND IN COMBINATION WITH CETUXIMAB IN TREATING RAS WILD-TYPE COLORECTAL CANCER

TREATMENT FOR OBESITY

PHARMACEUTICAL COMPOSITIONS COMPRISING POH DERIVATIVES

METHODS AND COMPOSITIONS FOR CANCER THERAPY

TREATMENT OF NEUTROPHILIC DERMATOSES

Pharmaceutical Combinations For The Treatment Of Cancer

TRANSDERMAL DELIVERY OF ANTIDIABETIC AGENTS

COMPOSITIONS AND METHODS FOR THE DELIVERY OF ACTIVE AGENTS INCLUDING NUCLEIC ACIDS

METHODS FOR THE TREATMENT OF PRESBYOPIA

METHOD FOR MORSELIZING AND/OR TARGETING PHARMACEUTICALLY ACTIVE PRINCIPLES TO SYNOVIAL TISSUE

METHODS OF TREATING PRIMARY LIVER TUMORS WITH NATURAL KILLER CELLS EXPRESSING A CYTOTOXIC RECEPTOR COMPLEX

Proteomic Risk Score For Adjudicated Arthropathy (AA)

METHODS OF USING PD-L1 EXPRESSION IN TREATMENT DECISIONS FOR CANCER THERAPY

METHOD OF TREATMENT OF HIV INFECTION WITH VACCINE

TREATMENT FOR OVARIAN CANCER WITH OLIGONUCLEOTIDES TARGETING FIBROBLAST ACTIVATION PROTEIN ALPHA

CELL THERAPY COMPOSITIONS AND METHODS OF USE THEREOF

BISPECIFIC HER2 AND CD3 BINDING MOLECULES

BISPECIFIC ANTIBODY TARGETING HK2 AND CD3 FOR THE TREATMENT OF PROSTATE CANCER

METHODS FOR TREATING CONDITIONS ASSOCIATED WITH MASP-2 DEPENDENT COMPLEMENT ACTIVATION

Pharmaceutical Formulation and Dosing Regimen for the Treatment of Amyotrophic Lateral Sclerosis

ANTI-PD-1 ANTIBODIES, OR FRAGMENTS THEREOF, FOR TREATING HEPATITIS B

Methods of Treating Red Blood Cell Disorders

METHODS OF ALTERING BONE GROWTH BY ADMINISTRATION OF SOST OR WISE ANTAGONIST OR AGONIST

COMPOUNDS

MODIFIED PEPTIDE FRAGMENTS OF CAV-1 PROTEIN AND THE USE THEREOF IN THE TREATMENT OF FIBROSIS

AZA-TETRACYCLIC OXAZEPINE COMPOUNDS AND USES THEREOF

CRYSTALLINE FORMS OF A BRUTONS TYROSINE KINASE INHIBITOR

PURINE DERIVATIVES AS SIK-3 INHIBITORS